Grant of Stock Options to Employees of the Company and Its Subsidiaries
First written in FY2023-Q2. 11 of 12 entries say "Advanced", first in FY2023-Q3. Latest entry: FY2026.
106 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Increase from a third-party allotment 5,756,200 shares Increase from the exercise of share acquisition rights 62,200 shares」
The exercise of share acquisition rights increased the number of shares by 62,200 during the fiscal year. The company also disclosed that 410,000 shares under the ninth series of share acquisition rights, resolved on 15 May 2026, would be granted to officers, employees and others. - FY2026-H1AdvancedAnnual report
「1 April 2025–30 September 2025 33,200 6,056,200 17,346 1,298,255 17,346 1,198,255 (Note) Increase due to the exercise of share acquisition rights.」
The exercise of share acquisition rights during the six-month consolidated period increased the number of shares by 33,200 and increased both stated capital and capital reserves by ¥17.346 million. - FY2025-H1AdvancedAnnual report
「1 April 2024–30 September 2024 97,500 5,955,000 4,755 1,250,179 4,755 1,150,179 (Note) Increase due to the exercise of share acquisition rights.」
The exercise of share acquisition rights during the six-month consolidated period increased the number of shares by 97,500 and increased both stated capital and capital reserves by ¥4.755 million. - FY2024AdvancedAnnual report
「1 April 2023–31 March 2024 126,300 5,857,500 6,372 1,245,424 6,372 1,145,424 (Note) Increase due to the exercise of share acquisition rights.」
The exercise of share acquisition rights during the consolidated fiscal year increased the number of shares by 126,300. The fifth and sixth series of share acquisition rights were also granted in January 2024. - FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 900 5,841,600 19 1,244,683 19 1,144,683 (Note) Increase due to the exercise of share acquisition rights.」
The exercise of share acquisition rights during the quarter increased the number of shares by 900 and increased both stated capital and capital reserves by ¥19 thousand. As a subsequent event, the fifth and sixth series of share acquisition rights were allocated to officers and employees on 9 January 2024. - FY2024-Q2AdvancedAnnual report
「1 July 2023–30 September 2023 66,300 5,840,700 2,311 1,244,663 2,311 1,144,663 (Note) Increase due to the exercise of share acquisition rights.」
The exercise of share acquisition rights during the quarter increased the number of shares by 66,300 and increased both stated capital and capital reserves by ¥2.311 million. - FY2024-Q1AdvancedAnnual report
「1 April 2023–30 June 2023 43,200 5,774,400 3,299 1,242,352 3,299 1,142,352 (Note) Increase due to the exercise of share acquisition rights.」
The exercise of share acquisition rights during the quarter increased the number of shares by 43,200 and increased both stated capital and capital reserves by ¥3.299 million. - FY2023-Q3AdvancedAnnual report
「In addition, the exercise of share acquisition rights increased both stated capital and capital surplus by ¥2.546 million.」
Of the share acquisition rights previously reported as granted to employees and others, 87,300 shares were exercised during the quarter, increasing both stated capital and capital surplus by ¥2.546 million. - FY2023-Q2First statedAnnual report
「At a meeting of its Board of Directors held on 14 November 2022, the company resolved to issue the fourth series of share acquisition rights to employees of the company and its subsidiaries pursuant to Articles 236, 238 and 240 of the Companies Act.」
The company resolved to issue 1,026 share acquisition rights, representing 102,600 underlying shares, to 27 company employees and 17 subsidiary employees. The exercise period runs from 1 December 2024 to 30 November 2026.